Use access key #2 to skip to page content.
$84.53 0.53 (0.63%)
1/7/2009 4:00 PM

Genentech, Inc. (DNA)

CAPS Rating:
****

The Company is a biotechnology company that discovers, develops, manufactures, and commercializes biotherapeutics for unmet medical needs.

View All Commentary (DNA)

Recs

0

Avatar Roosters2006 (31.60) Submitted: 12/05/07 9:48 PM : Underperform Start Price: $67.62 DNA Score: -64.50

While I think the explosive growth period is over for this stock, it will still outperforma the market as we are all getting older and the need for more advanced medicines will only increase. DNA is one of the leading players and will lead the way with new drugs and treatments.

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners

Sponsored Links